Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancement.
J Pharmacol Exp Ther
; 353(1): 119-31, 2015 Apr.
Article
in En
| MEDLINE
| ID: mdl-25653417
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Serine Endopeptidases
/
Proprotein Convertases
/
Cholesterol, LDL
/
Antibodies, Monoclonal
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2015
Document type:
Article
Country of publication:
Estados Unidos